Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M964Revenue (TTM) $M159Net Margin (%)11.4Altman Z-Score9.0
Enterprise Value $M925EPS (TTM) $0.3Operating Margin %12.3Piotroski F-Score4
P/E(ttm)61.0Beneish M-Score-1.9Pre-tax Margin (%)12.0Higher ROA y-yN
Price/Book7.510-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales6.35-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow38.3y-y EBITDA Growth Rate %-50.5ROA % (ttm)10.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)16.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M49.4ROIC % (ttm)31.1Gross Margin Increase y-yN

Gurus Latest Trades with SUPN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SUPNRobert Bruce 2016-03-31 Reduce-0.12%$10.13 - $15.65
($13.02)
$ 19.5150%Reduce -11.78%224,581
SUPNJoel Greenblatt 2016-03-31 Reduce$10.13 - $15.65
($13.02)
$ 19.5150%Reduce -48.08%17,552
SUPNRobert Bruce 2015-12-31 Reduce-0.57%$12.78 - $18.86
($15.48)
$ 19.5126%Reduce -35.48%254,581
SUPNJoel Greenblatt 2015-12-31 Reduce$12.78 - $18.86
($15.48)
$ 19.5126%Reduce -13.63%33,808
SUPNRobert Bruce 2015-09-30 Reduce-1.5%$13.62 - $21.26
($18.58)
$ 19.515%Reduce -43.19%394,581
SUPNJoel Greenblatt 2015-09-30 Reduce-0.01%$13.62 - $21.26
($18.58)
$ 19.515%Reduce -55.66%39,142
SUPNGeorge Soros 2015-06-30 Sold Out -0.01%$12.09 - $18.37
($14.2)
$ 19.5137%Sold Out0
SUPNJoel Greenblatt 2015-06-30 Add0.01%$12.09 - $18.37
($14.2)
$ 19.5137%Add 111.74%88,267
SUPNGeorge Soros 2015-03-31 Buy 0.01%$8.18 - $12.09
($9.45)
$ 19.51106%New holding107,308
SUPNJoel Greenblatt 2015-03-31 Buy $8.18 - $12.09
($9.45)
$ 19.51106%New holding41,686
SUPNRobert Bruce 2014-12-31 Add0.68%$7.49 - $9.49
($8.4)
$ 19.51132%Add 73.65%694,581
SUPNRobert Bruce 2014-09-30 Add0.73%$7.99 - $11.13
($8.98)
$ 19.51117%Add 300.00%400,000
SUPNRobert Bruce 2014-06-30 Buy 0.25%$7.32 - $10.85
($8.88)
$ 19.51120%New holding100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SUPN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


SUPN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bhatt Padmanabh P.Sr. VP of IP, CSO 2016-04-11Sell30,762$16.4918.31view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-12-09Sell14,238$14.930.94view
BARRETT M JAMESDirector 2015-12-08Sell212,970$14.5634view
BARRETT M JAMESDirector 2015-11-25Sell16,179$16.3519.33view
BARRETT M JAMESDirector 2015-11-18Sell93,000$16.6117.46view
BARRETT M JAMESDirector 2015-11-16Sell119,650$16.2420.14view
Bhatt Padmanabh P.Sr. VP of IP, CSO 2015-11-04Sell5,000$19.9-1.96view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-28Sell2,350$21.2-7.97view
PATRICK GREGORY SVP, CFO 2015-07-16Sell6,217$20-2.45view
Schwabe Stefan K.F.Executive Vice President R&D 2015-07-13Sell1,950$19.231.46view

Quarterly/Annual Reports about SUPN:

News about SUPN:

Articles On GuruFocus.com
Robert Bruce new Buys Feb 16 2015 
Third Quarter Was Robert Bruce's Busiest in 2014 Nov 21 2014 
Supernus Pharmaceuticals Reports Insider Buys Mar 26 2013 

More From Other Websites
5 stocks to watch May 26 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 25 2016
Supernus to Present at June Jefferies Healthcare Conference May 24 2016
Supernus to Present at June Jefferies Healthcare Conference May 24 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 19 2016
SUPERNUS PHARMACEUTICALS INC Financials May 18 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 10 2016
Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XR® May 10 2016
Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XR® May 10 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report May 10 2016
Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US :... May 09 2016
Edited Transcript of SUPN earnings conference call or presentation 4-May-16 1:00pm GMT May 04 2016
Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today May 04 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2016
Supernus Announces First Quarter 2016 Financial Results May 03 2016
Supernus Announces First Quarter 2016 Financial Results May 03 2016
Q1 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close May 03 2016
SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 19 2016
Supernus to Host First Quarter 2016 Earnings Conference Call Apr 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)